AKSIAL SPONDILOARTRITNI DAVOLASHDA O‘SMA NEKROZI OMILI INGIBITORINING  SAMARADORLIGINI O‘RGANISH

Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/1185

Full metadata record

DC Field	Value	Language
dc.contributor.author	Nabiуeva D.A., Muhammadiуeva S.M., Ziyaуeva F.K.	-
dc.date.accessioned	2025-04-04T08:57:07Z	-
dc.date.available	2025-04-04T08:57:07Z	-
dc.date.issued	2025	-
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/1185	-
dc.description.abstract	Maqsad: aksial spondiloartrit bemorlarni davo lashda INF dori vositasining samaradorligini baholash. Material va usullar: tadqiqotga faol AKSSPA (BASDAI faollik indeksi >4) bilan kasallangan hamda standart terapiya samara bermagan 53 ta bemorga O‘NO-α ingi bitori - infliksimab dori vositasi 3-5 mg/kg dozada/tana vazniga tomir ichiga 0, 2, 6 haftalarda va keyinchalik har 8 haftada qo‘llanildi. Natijalar: infliksimab bilan davol angan bemorlarda BASDAI va BASMI indekslari bo‘yicha aniq klinik samaraga erishildi, umurtqa pog‘onasi harakatchanligi indekslari hamda BASFI indeksi dina mikasida ham ijobiy natija aniqlandi. INF ning bemor lar tomonidan qabul qilinishi qoniqarli bo‘ldi.Xulosa: INF bilan davolashning dastlabki bosqichida, umurtqa pog‘onasidagi harakatlarning sezilarli darajada oshishi kuzatildi.	en_US
dc.language.iso	other	en_US
dc.publisher	O'zbekiston, Toshkent	en_US
dc.relation.ispartofseries	UO’К;616.72-004.2:616.12-002	-
dc.subject	ankilozlovchi spondiloartrit, diagnos tika, davolash, O‘NO-α ingibitorlari, infliksimab.	en_US
dc.title	AKSIAL SPONDILOARTRITNI DAVOLASHDA O‘SMA NEKROZI OMILI INGIBITORINING SAMARADORLIGINI O‘RGANISH	en_US
dc.type	Article	en_US
Appears in Collections:	Articles

Files in This Item:

File	Description	Size	Format
Вестник ТМА №3 2025_107-112 стр..pdf	AKSIAL SPONDILOARTRITNI DAVOLASHDA O‘SMA NEKROZI OMILI INGIBITORINING SAMARADORLIGINI O‘RGANISH	842.78 kB	Adobe PDF	View/Open

DSpace JSPUI